Takeda: all 1,753 studies

Page 3 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• A Study of TAK-071 in People With Parkinson DiseaseCompletedNCT04334317Phase 2Results posted
• Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 YearsCompletedNCT04313244Phase 3Results posted
• Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"CompletedNCT04285983Results posted
• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune ThrombocytopeniaCompletedNCT04278924Phase 2Results posted
• A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)TerminatedNCT04272775Phase 1Results posted
• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive ChemotherapyCompletedNCT04266795Phase 2Results posted
• Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"CompletedNCT04213209Results posted
• A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)CompletedNCT04206605Phase 3Results posted
• A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy ParticipantsTerminatedNCT04202497Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori InfectionCompletedNCT04198363Phase 3Results posted
• Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)CompletedNCT04180163Phase 3Results posted
• A Study of TAK-079 in People With Generalized Myasthenia GravisCompletedNCT04159805Phase 2Results posted
• A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male ParticipantsCompletedNCT04155567Phase 1Results posted
• A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult ParticipantsTerminatedNCT04131556Phase 1Results posted
• A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult ParticipantsCompletedNCT04121078Phase 1Results posted
• A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal FistulaTerminatedNCT04118088Phase 4Results posted
• A Study of TAK-994 in Adults With Type 1 and Type 2 NarcolepsyTerminatedNCT04096560Phase 2Results posted
• A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaCompletedNCT04091438Phase 1Results posted
• A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT04085172Phase 4Results posted
• Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaCompletedNCT04075825Phase 3Results posted
• A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin LymphomaTerminatedNCT04074330Phase 1/2Results posted
• A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in ChildrenCompletedNCT04070326Phase 3Results posted
• FIRAZYR General Drug Use-Results Survey (Japan)CompletedNCT04057131Results posted
• A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic FunctionCompletedNCT04056468Phase 1Results posted
• A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy KidneysCompletedNCT04056455Phase 1Results posted
• Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT04051827Phase 1Results posted
• Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster DoseCompletedNCT03999996Phase 3Results posted
• A Study of SHP655 (rADAMTS13) in Sickle Cell DiseaseCompletedNCT03997760Phase 1Results posted
• Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)CompletedNCT03990649Phase 2Results posted
• Perianal Fistula (PAF) Validation and Burden of Illness StudyCompletedNCT03981939Results posted
• A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy ParticipantsCompletedNCT03961308Phase 1Results posted
• A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy ParticipantsCompletedNCT03961295Phase 1Results posted
• A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy ParticipantsCompletedNCT03949621Phase 1Results posted
• A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy ParticipantsCompletedNCT03948581Phase 1Results posted
• A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After SurgeryTerminatedNCT03943446Phase 2Results posted
• A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult ParticipantsCompletedNCT03928327Phase 1Results posted
• Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)CompletedNCT03922308Phase 2Results posted
• A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.CompletedNCT03918239Phase 1Results posted
• A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese ParticipantsCompletedNCT03888755Phase 3Results posted
• A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)CompletedNCT03879135Phase 3Results posted
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult ParticipantsCompletedNCT03870555Phase 1Results posted
• Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult ParticipantsCompletedNCT03866434Phase 1Results posted
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult ParticipantsCompletedNCT03859323Phase 1Results posted
• A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult ParticipantsCompletedNCT03849690Phase 1Results posted
• A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After SurgeryCompletedNCT03827655Phase 2Results posted
• Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]CompletedNCT03824561Results posted
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCompletedNCT03814005Phase 1Results posted
• A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy ParticipantsCompletedNCT03811834Phase 1Results posted
• A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) TabletCompletedNCT03808493Phase 1Results posted
• A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung CancerActive, not recruitingNCT03807778Phase 1Results posted
• A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release CapsulesCompletedNCT03801148Phase 1Results posted
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy AdultsCompletedNCT03771963Phase 3Results posted
• A Study of Intrathecal SHP611 in Children With Metachromatic LeukodystrophyCompletedNCT03771898Phase 2Results posted
• Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian CancerCompletedNCT03759600Phase 2Results posted
• Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian CancerCompletedNCT03759587Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With NarcolepsyCompletedNCT03748979Phase 1Results posted
• Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)CompletedNCT03748953Phase 3Results posted
• Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune AdultsCompletedNCT03746015Phase 2Results posted
• Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac DiseaseCompletedNCT03738475Phase 2Results posted
• Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"CompletedNCT03729609Results posted
• Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"CompletedNCT03727139Results posted
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)CompletedNCT03724916Phase 1Results posted
• A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) ParticipantsCompletedNCT03710486Results posted
• A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid TumorsCompletedNCT03708211Phase 1Results posted
• Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's DiseaseCompletedNCT03706456Phase 3Results posted
• A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac DiseaseCompletedNCT03701555Phase 1Results posted
• A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)CompletedNCT03694275Phase 2Results posted
• A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy ParticipantsCompletedNCT03666858Results posted
• Study of Teduglutide in Japanese Participants With Short Bowel SyndromeCompletedNCT03663582Phase 3Results posted
• Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) TransplantationCompletedNCT03657160Phase 3Results posted
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesCompletedNCT03650452Phase 2Results posted
• A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune SystemTerminatedNCT03648372Phase 1/2Results posted
• A Study of Soticlestat in Adults and Children With Rare EpilepsiesTerminatedNCT03635073Phase 2Results posted
• Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)TerminatedNCT03627091Phase 3Results posted
• Agrylin Drug Use-Result SurveyCompletedNCT03625895Results posted
• Survey Study for Velaglucerase Alfa (VPRIV) in JapanCompletedNCT03625882Results posted
• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung CancerCompletedNCT03596866Phase 3Results posted
• An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004CompletedNCT03596164Phase 3Results posted
• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic LeukemiaActive, not recruitingNCT03589326Phase 3Results posted
• A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular CarcinomaCompletedNCT03586973Phase 2Results posted
• Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel SyndromeCompletedNCT03571516Phase 3Results posted
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)TerminatedNCT03566823Phase 3Results posted
• RIXUBIS PMS India (RIXUBIS PMS)CompletedNCT03565237Phase 4Results posted
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)TerminatedNCT03559517Phase 3Results posted
• Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"CompletedNCT03555591Results posted
• Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"CompletedNCT03555565Results posted
• A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic GastroparesisCompletedNCT03544229Phase 2Results posted
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibCompletedNCT03535740Phase 2Results posted
• A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean ParticipantsCompletedNCT03535649Results posted
• A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life PracticeCompletedNCT03532932Results posted
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus VaccineCompletedNCT03525119Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy AdultsCompletedNCT03522506Phase 1Results posted
• Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational AnalysisCompletedNCT03506386Results posted
• A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian ParticipantsCompletedNCT03501277Phase 1Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female ParticipantsTerminatedNCT03501069Phase 1Results posted
• A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male ParticipantsCompletedNCT03500224Phase 1Results posted
• A Study of Niraparib as Single Agent in Participants With Advanced Solid TumorsCompletedNCT03497429Phase 1Results posted
• A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)CompletedNCT03488030Results posted
• Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac DiseaseCompletedNCT03486990Phase 1Results posted
• A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid TumorsCompletedNCT03486314Phase 1Results posted

← Takeda overview and focus areas